Diagnosing asthma can sometimes be challenging. While symptoms such as wheezing, coughing, and shortness of breath are common indicators, confirming the diagnosis often requires additional testing. Traditionally, doctors rely on lung function tests such as spirometry, peak flow monitoring, and bronchodilator response tests. These methods focus on identifying changes in airway function. However, these tests do not always detect asthma, particularly in patients with mild sympto

Breath testing is a powerful, non-invasive diagnostic tool, but accurate results depend on correct sampling. Learn why breath-holding and end-tidal samples are essential for reliable breath analysis.

Atopic dermatitis (AD), commonly known as eczema, is a chronic inflammatory skin condition that often occurs alongside other allergic diseases like allergic rhinoconjunctivitis (ARC) and asthma. The triggers for these allergic conditions,  especially pollens, can vary widely depending on geographic region and local exposure.

Climate change is acknowledged as a significant risk to global health, and South Africa is particularly vulnerable, experiencing warming at a rate 1.5 times faster than the global average (Upton & Peter, 2025). This alarming trend exacerbates respiratory health risks, increasing the rates of asthma and other allergic respiratory diseases due to extreme weather events, poor air quality, and rising aeroallergen levels.    The Climate Crisis in South Africa  As detailed in the n

Advanced IgE testing is transforming how atopic dermatitis is understood and diagnosed. By analysing hundreds of allergen components, researchers reveal hidden cross-reactivity patterns that help explain persistent eczema, asthma, and allergic rhinitis. This insight supports more precise, personalised allergy diagnosis using modern molecular testing.

Discover how Molecular Allergy Diagnosis (MAD) and the advanced ALEX2 multiplex system are transforming the way healthcare professionals identify and treat seasonal allergies. New research reveals how MAD overcomes the limitations of traditional testing by eliminating cross-reactivity and delivering highly accurate, patient-specific results. Explore why this next-generation approach is redefining allergy diagnosis and improving outcomes for allergy sufferers.